Seagen Inc (SGEN) President and CEO Clay B Siegall Sold $4.3 million of Shares
- By insider
President and CEO of Seagen Inc (30-Year Financial, Insider Trades) Clay B Siegall (insider trades) sold 29,353 shares of SGEN on 03/04/2021 at an average price of $145.74 a share. The total sale was $4.3 million.
Seattle Genetics Inc is a biotechnology company. The company is focused on development and commercialization of targeted therapies for the treatment of cancer. Its products are ADCETRIS (brentuximab vedotin) US and ADCETRIS (brentuximab vedotin) Canada. Seagen Inc has a market cap of $27.06 billion; its shares were traded at around $149.350000 with a P/E ratio of 45.25 and P/S ratio of 12.41.
CEO Recent Trades:
President and CEO Clay B Siegall sold 29,353 shares of SGEN stock on 03/04/2021 at the average price of $145.74. The price of the stock has increased by 2.48% since.
President and CEO Clay B Siegall sold 29,353 shares of SGEN stock on 02/04/2021 at the average price of $165.57. The price of the stock has decreased by 9.8% since.
Directors and Officers Recent Trades:
Chief Technical Officer Vaughn B Himes sold 12,000 shares of SGEN stock on 03/02/2021 at the average price of $153.22. The price of the stock has decreased by 2.53% since.
For the complete insider trading history of SGEN, click here
.This article first appeared on GuruFocus.
